Paratek Pharmaceuticals, Inc. (PRTK): Price and Financial Metrics

PRTK POWR Grades

• PRTK scores best on the Value dimension, with a Value rank ahead of 79.11% of US stocks.
• The strongest trend for PRTK is in Stability, which has been heading up over the past 179 days.
• PRTK's current lowest rank is in the Momentum metric (where it is better than 4.64% of US stocks).

PRTK Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for PRTK is -1.02 -- better than merely 4.13% of US stocks.
• PRTK's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 4.46% of US stocks.
• Revenue growth over the past 12 months for Paratek Pharmaceuticals Inc comes in at 177.39%, a number that bests 95.37% of the US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to Paratek Pharmaceuticals Inc are OSIS, QUOT, HRMY, ISR, and REKR.
• Visit PRTK's SEC page to see the company's official filings. To visit the company's web site, go to paratekpharma.com.

PRTK Valuation Summary

• PRTK's EV/EBIT ratio is -12.7; this is 143.34% lower than that of the median Healthcare stock.
• Over the past 153 months, PRTK's price/sales ratio has gone up 2.3.
• PRTK's EV/EBIT ratio has moved down 13.1 over the prior 153 months.

Below are key valuation metrics over time for PRTK.

PRTK Growth Metrics

The year over year net income to common stockholders growth rate now stands at 27.75%.
• The 2 year price growth rate now stands at -58.75%.
• The 2 year net cashflow from operations growth rate now stands at -76.91%.

Over the past 15 months, PRTK's revenue has gone up $90,290,000.

The table below shows PRTK's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	130.162	-48.273	-59.084
2021-09-30	114.387	-52.315	-51.841
2021-06-30	103.599	-107.493	-54.494
2021-03-31	55.433	-94.616	-87.27
2020-12-31	46.924	-103.424	-96.541
2020-09-30	39.872	-115.104	-98.896

PRTK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PRTK has a Quality Grade of D, ranking ahead of 16.58% of graded US stocks.
• PRTK's asset turnover comes in at 0.58 -- ranking 64th of 680 Pharmaceutical Products stocks.
• BHVN, EVFM, and IBRX are the stocks whose asset turnover ratios are most correlated with PRTK.

The table below shows PRTK's key quality metrics over time.